Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals

2 Jul 2024

Abstract excerpt

Abstract Blood-based biomarkers of Alzheimer disease (AD) may facilitate testing of historically under-represented groups. The Study of Race to Understand Alzheimer Biomarkers (SORTOUT-AB) is a multi-center longitudinal study to compare AD biomarkers in participants who identify their race as either Black or white. Plasma samples from 324 Black and 1,547 white participants underwent analysis with C2N Diagnostics’...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Heavy Metal Exposure and Toxicity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38956096
DOI: 10.1038/s41467-024-49859-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individualsPMID 38956096Read ↗

Baseline levels and longitudinal rates of change in plasma Aβ42/40 among self-identified Black/African American and White individualsSemantic proximity Read ↗

Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Aβ ratioSemantic proximity Read ↗

Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseSemantic proximity Read ↗

Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high‐risk cohort of middle‐aged adultsSemantic proximity Read ↗

Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in PlasmaSemantic proximity Read ↗

Association of Alzheimer's disease genetic risk with age-dependent changes in plasma amyloid-β42:40 in Veterans.Semantic proximity Read ↗

Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trialSemantic proximity Read ↗

Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer's diseaseSemantic proximity Read ↗

Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White IndividualsSemantic proximity Read ↗

Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.Semantic proximity Read ↗

Racial differences in the effect of APOE-ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.